A. Roughley

Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015

J. Piercy, V. Higgins, A. Roughley, 2016, Diabetes, metabolic syndrome and obesity : targets and therapy.

The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study

A. Roughley, S. Iyer, A. Rider, 2013, Supportive Care in Cancer.

Reasons for nonuse of antiviral treatment in patients with chronic hepatitis C infection and thrombocytopaenia: a retrospective chart review from five European countries

W. Irving, M. Rizzetto, U. Forssén, 2014, Journal of viral hepatitis.

PCN94 HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN 1ST LINE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN A REAL LIFE SETTING: BEVACIZUMAB-BASED VERSUS NON-BEVACIZUMAB BASED THERAPY IN A EUROPEAN PILOT STUDY

S. Walzer, C. Chouaid, A. Roughley, 2011 .

Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn’s Disease or Ulcerative Colitis in the United States

E. Muser, A. Roughley, J. Kershaw, 2022, Crohn's & colitis 360.

Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany.

A. Roughley, S. Iyer, G. Taylor‐Stokes, 2013, Lung cancer.

Satisfaction with control of systemic lupus erythematosus and lupus nephritis: physician and patient perspectives

A. Roughley, N. Mozaffarian, S. Lobosco, 2016, Patient preference and adherence.

Impact of Brain Metastases on Quality of Life and Estimated Life Expectancy in Patients with Advanced Non-Small Cell Lung Cancer.

A. Roughley, A. Rider, G. Taylor‐Stokes, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Confidence in correct inhaler technique and its association with treatment adherence and health status among US patients with chronic obstructive pulmonary disease

Mark Small, A. Amin, A. Roughley, 2017, Patient preference and adherence.

Real-world treatment patterns and outcomes of patients with stage IV squamous cell carcinoma of the head and neck.

J. Martini, A. Roughley, S. Iyer, 2019, Future oncology.